While existing studies do not entirely rule out a link between the development of thyroid cancer (both medullary and papillary) and the use of GLP-1 RAs, clinical trials suggest no significant correlation between these occurrences in humans [88]. Here, GCG is linked to thyroid gland carcinoma.